About
Chinese marketed drugs
Areas of Focus
Categories
Small Molecule PharmaceuticalGeneric DrugChina
Clinical Trials (8)
View allTotal Trials
8
As Lead Sponsor
8
As Collaborator
0
Total Enrollment
790
By Phase
PHASE3: 1PHASE1: 3PHASE2: 2PHASE1/PHASE2: 2
By Status
COMPLETED: 6NOT_YET_RECRUITING: 1UNKNOWN: 1
Clinical Trials Pipeline8 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT07037875Lead Sponsor
A Study Comparing the Effect and Safety of Linaprazan Glurate to Lansoprazole in Participants With Erosive Esophagitis (EE) Due to Gastroesophageal Reflux Disease (GERD)
PHASE3Not yet recruiting
500 participants
Started: Sep 30, 2025 · Completed: Sep 30, 2026
NCT05742984Lead Sponsor
Investigate Linaprazan Glurate/Linaprazan in Healthy Subjects
PHASE1Completed
75 participants
Started: Jan 26, 2023 · Completed: Apr 13, 2023
NCT05633147Lead Sponsor
Effect of Clarithromycin on PK of Linaprazan, Linaprazan on PK of Clarithromycin and Linaprazan on PK of Midazolam
PHASE1Completed
35 participants
Started: Nov 27, 2022 · Completed: May 30, 2023
NCT05627518Lead Sponsor
Relative Bioavailability of Linaprazan for the Test Formulation vs. Reference Formulation
PHASE1Completed
67 participants
Started: Nov 15, 2022 · Completed: Jan 3, 2023
NCT05889351Lead Sponsor
Study to Evaluate the Efficacy, Safety and Tolerability of 3% LTX-109 for Nasal Decolonisation of Staphylococcus Aureus
PHASE2Completed
27 participants
Started: Sep 19, 2022 · Completed: Oct 28, 2022
Locations (1)
Headquarters
Haikou, China
Map
Loading map...